Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
PBR $ 10.84 1.13 ▲ 11.64%
BAC $ 17.12 0.12 ▲ 0.71%
INTC $ 35.59 0.36 ▼ 1.00%
AAPL $ 116.47 0.16 ▲ 0.14%
KMI $ 39.75 0.17 ▼ 0.43%
VALE $ 9.41 0.72 ▲ 8.29%
MSFT $ 47.98 0.72 ▼ 1.48%
KMP $ 97.34 0.56 ▼ 0.57%

As of 11/21/2014, 04:15 PM
More Most Active